Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Haleon PLC ( (GB:HLN) ) has provided an announcement.
Haleon plc has confirmed that, as of 31 March 2026, it has 8,931,093,261 issued ordinary shares, of which 12,548,735 are held in treasury, leaving 8,918,544,526 shares carrying voting rights. This updated share capital and voting rights figure provides the official denominator for investors and other stakeholders to assess and report their notifiable interests in the company under UK disclosure and transparency rules.
The clarification of Haleon’s voting share count ensures greater transparency for shareholders, supports accurate regulatory reporting and helps maintain orderly disclosure practices in the market. By formalising the number of shares with voting rights, the company provides a clear reference point for institutional investors and other market participants tracking ownership thresholds and governance influence.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £450.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
The score is driven primarily by solid financial performance (consistent free cash flow and improving profitability) and a cautiously positive earnings outlook supported by margin gains and cost savings. This is tempered by weaker near-term technical momentum and only moderate valuation support.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC
Haleon plc is a consumer health company focused on improving everyday health through a portfolio spanning oral health, vitamins, minerals and supplements, pain relief, respiratory health, digestive health, and therapeutic skin health. Its well-known brands, including Advil, Centrum, Panadol, Sensodyne and Voltaren, reach more than a billion consumers and are widely recommended by health professionals worldwide.
Average Trading Volume: 19,872,086
Technical Sentiment Signal: Strong Buy
Current Market Cap: £33.34B
Learn more about HLN stock on TipRanks’ Stock Analysis page.